Steven R. GoodmanSteven R. Goodman, Ph.D. serves as Vice Chancellor for Research at The University of Tennessee Health Science Center (UTHSC) where he also serves as Professor in the Departments of Pediatrics and Physiology in the College of Medicine; with additionalappointments in the College of Dentistry, College of Graduate of Health Sciences, College of Health Professions, College of Nursing, and College of Pharmacy. Dr. Goodman has led creation of the Clinical Trials Network of Tennessee (CTN2) and serves as the President and CEO of CTN2.
Steve is known globally for his four decades of research into the structure and function of cell structures called membrane skeletons. His related research into sickle cell disease led to defining the molecular basis of the irreversibly sickle cell and his recent proteomic studies led to potential biomarkers for sickle cell severity. Dr. Goodman’s research accomplishments have led to his becoming a recipient of the Society of Experimental Biology and Medicine (SEBM) Distinguished Scientist Award and his election as a 2016 American Association for the Advancement of Science (AAAS) Fellow.
Dr. Goodman is a Past President of the Association of Anatomy, Cell Biology and Neurobiology Chairs (AACBNC). Steve serves on multiple editorial boards and has been Editor-in-Chief of Experimental Biology and Medicine (EBM) since July 2006. Since becoming Editor-in-Chief of EBM, Dr. Goodman has globalized SEBM and EBM opening offices in Tainan, Taiwan, London, Great Britain, Chengdu, China, Campinas, Brazil and most recently Ghana Africa. Steve hopes that you enjoy his 4th Edition of Goodman’s Medical Cell Biology. Read More Read Less